Yongji Tian1, Shenglin Yue, Ge Jia, Yuqi Zhang. 1. Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, PR China.
Abstract
OBJECTIVE: Pituicytoma is a rare, benign, primary tumour, almost all of which occur in adults. Here, we present one case of giant pituicytoma in a boy and a review literature to assist in understanding its natural history, behaviour, clinicopathological features and treatment options. METHODS: A PUBMED search using the keywords "pituicytoma" was performed, and the citations were reviewed. RESULTS: We found 65 cases of pituicytomas, including our report, in the international literature to date; among these cases, only three were diagnosed in patients under 14 years old. CONCLUSION: Pituicytoma is a slow-growing, rare, low-grade glial neoplasm that originates in the neurohypophysis. Currently, the optimal treatment is gross total resection, and confirmed diagnosis relies upon pathological tests. Regular MRI follow-up is recommended.
OBJECTIVE: Pituicytoma is a rare, benign, primary tumour, almost all of which occur in adults. Here, we present one case of giant pituicytoma in a boy and a review literature to assist in understanding its natural history, behaviour, clinicopathological features and treatment options. METHODS: A PUBMED search using the keywords "pituicytoma" was performed, and the citations were reviewed. RESULTS: We found 65 cases of pituicytomas, including our report, in the international literature to date; among these cases, only three were diagnosed in patients under 14 years old. CONCLUSION: Pituicytoma is a slow-growing, rare, low-grade glial neoplasm that originates in the neurohypophysis. Currently, the optimal treatment is gross total resection, and confirmed diagnosis relies upon pathological tests. Regular MRI follow-up is recommended.
Authors: Eduardo de Arnaldo Silva Vellutini; Pedro Henrique Petit Becker; Luis Felipe Godoy; Nicolau Faria Correia Guerreiro; Romulo Loss Mattedi; Matheus Fernandes de de Oliveira Journal: Surg Neurol Int Date: 2018-07-24